Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis

The traditional endpoint for assessing efficacy of chemotherapies for advanced/recurrent gastric cancer is overall survival (OS), but OS requires prolonged follow-up. We investigated whether progression-free survival (PFS) is a valid surrogate for OS. Using individual patient data from the GASTRIC m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Paoletti, Xavier, Oba, Koji, Bang, Yung-Jue, Bleiberg, Harry, Boku, Narikazu, Bouché, Olivier, Catalano, Paul, Fuse, Nozomu, Michiels, Stefan, Moehler, Markus, Morita, Satoshi, Ohashi, Yasuo, Ohtsu, Atsushi, Roth, Arnaud, Rougier, Philippe, Sakamoto, Junichi, Sargent, Daniel, Sasako, Mitsuru, Shitara, Kohei, Thuss-Patience, Peter, Van Cutsem, Eric, Burzykowski, Tomasz, Buyse, Marc
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2013
Assuntos:
Brief Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4994928/
https://ncbi.nlm.nih.gov/pubmed/24108811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt269
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados